Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Neumora Therapeutics

Request full access

Pioneering a new era of precision medicines for brain diseases

Watertown, United StatesFounded 2020Biotech & Life Sciences

About Neumora Therapeutics

Neumora Therapeutics is pioneering the development of precision medicines for brain diseases, addressing the unmet needs in neuropsychiatric and neurodegenerative disorders. The company operates in the biopharmaceutical sector, focusing on Central Nervous System (CNS) diseases. Neumora's business model revolves around leveraging its proprietary Precision Toolbox, which integrates translational, clinical, and computational tools to develop targeted treatments. This approach aims to revolutionize the treatment landscape by focusing on novel mechanisms of action, rather than traditional drug classes. Neumora serves patients suffering from brain diseases, a market that affects over 1.5 billion people globally. The company generates revenue through the development and commercialization of its innovative drug pipeline, which is designed to offer more effective and targeted treatment options.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2023

Neumora Therapeutics in the Watertown ecosystem

Live from Dealroom

The Neumora Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

20 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A16 investors entered at this stage

Series B and later4 investors entered at this stage

  • Exor
  • Newpath Partners
  • Abu Dhabi Growth Fund
  • Scripps Translational Science Institute
Employees mapped 106 incl. 3 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 16 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$38M

30 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Neumora Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.